Sleep Disorders Trial, Recruiting NCT05939934 Sponsor: University Hospital, Angers Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05939934
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing to use a Mandibular Advancement Device (MAD), which is a type of mouthguard worn during sleep to help keep the airway open
  • People whose initial sleep test showed more than 15 breathing interruptions per hour during sleep
  • People who experience excessive daytime sleepiness at the start of treatment, based on a specific sleepiness score (above 10 on the Epworth Sleepiness Scale)
  • People who have been using a CPAP machine (a device that delivers pressurised air to keep the airway open during sleep) for more than 12 months, averaging more than 5 hours of use per night

Who may not be able to join:

  • People whose initial assessment showed severe daytime sleepiness of a specifically characterised type (confirm with trial site)
  • People whose initial sleep test showed 5 or more central apneas (breathing pauses caused by the brain rather than a blocked airway) per hour of sleep
  • People who have previously been diagnosed with a serious heart or lung condition
  • People with a Body Mass Index (a measure of body weight relative to height) of 35 or above
  • People who have a known medical reason why they cannot use an oral device for sleep apnea treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: wojciech Trzepizur, MD PHD, University Hospital, Angers

Phone: +3380575272

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Angers
Registry
ClinicalTrials.gov
Start date
5 March 2024
Est. completion
1 November 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Change in subjective sleepiness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov